Robbins LLP Is Investigating the Officers and Directors of Insmed, Inc. (INSM) on Behalf of Shareholders
Robbins LLP is investigating whether certain officers and directors of Insmed, Inc. (NASDAQGS: INSM) breached their fiduciary duties to shareholders by misleading investors about the company’s lead product candidate. Insmed, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapies for patients with serious lung diseases.
Insmed Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.